Therapixel is the designer and supplier of MammoScreenⓇ an Artificial Intelligence software reading aid for mammography. Armed with two FDA regulatory clearances in the United States for both 2D and 3D (tomosynthesis) mammography, MammoScreen is already being deployed across large networks of breast cancer screening clinics. MammoScreen uses a unique score, MammoScreen Score™ to signal at a glance the level of suspicion of a mammogram.
- FDA approved and marked CE.
- Winner of the Digital Mammography DREAM Challenge